EMEA-000954-PIP01-10

Key facts

Active substance
grass pollen
Therapeutic area
Pneumology-allergology
Decision number
P/325/2010
PIP number
EMEA-000954-PIP01-10
Pharmaceutical form(s)
Suspension for injection
Condition(s) / indication(s)
  • Treatment of allergic rhinitis
  • Treatment of rhino-conjuctivitis
Route(s) of administration
Subcutaneous use
Contact for public enquiries
ROXALL Medizin GmbH
info@roxall.de
Germany
Phone: +49 408972520
Fax: +49 4089725223
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating